Apicore Pharmaceuticals Private Limited - Company Profile

It is a pharma foreign private limited company based in Padra, Gujarat, India, established in 2006.
2006 Padra, Gujarat, India Active
Last Updated:
Access Report
About Apicore Pharmaceuticals Private Limited

Apicore Pharmaceuticals Private Limited, a active foreign private limited company, was established on 27 July 2006 in Padra, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24119GJ2006FTC048777. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹51.00 Cr and a paid-up capital of ₹50.12 Cr.

It upholds a compliant status. Employing 471 professional, Its leadership includes Murali Krishna Madala (Managing Director), Mahesh Suresh Javale (Nominee Director), Ravishanker Kovi (Director). Past directors included Murali Krishna Madala, Mahesh Suresh Javale, Jay Vallabh Dhaduk. It holds ₹467.59 Cr open charges and ₹31.58 Cr settled loans. Its latest AGM occurred on 24 October 2024, with the balance sheet filed on 31 March 2024. It is based at Block No. 252-253, Village - Dhobikuva,, Padra, Gujarat, 391440.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24119GJ2006FTC048777

  • Registration Number

    048777

  • Incorporation Date

    27 July 2006

  • Authorized Capital

    ₹51.00 Cr

  • Paid-Up Capital

    ₹50.12 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 51.00 Cr
  • Paid Up Capital ₹ 50.12 Cr
  • Company Age 19 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 467.59 Cr
  • Satisfied Charges ₹ 31.58 Cr
  • Revenue Growth **** 17.41%
  • Profit Growth **** -325.99%
  • Ebitda **** -48.11%
  • Net Worth -40.83%
  • Total Assets **** 90.98%
Company report

Apicore Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apicore Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Apicore Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Murali Krishna Madala Managing Director 21 May 2018 Current
Mahesh Suresh Javale Nominee Director 12 Nov 2023 Current
Ravishanker Kovi Director 27 Jul 2006 Current
Parthiv Mahendrabhai Patel Director 21 May 2018 Current
Jayaraman Kannappan Whole-Time Director 19 Nov 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director Appointed In Casual Vacancy 29 Dec 2023 Past
Pramod Abcsdd Additional Director 29 Dec 2023 Past
Pramod Abcsdd Director 18 Dec 2014 Past
Pramod Abcsdd Director 18 Dec 2014 Past
Pramod Abcsdd Director 18 Dec 2014 Past
Pramod Abcsdd Director 16 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apicore Pharmaceuticals.

Apicore Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.41% increase. The company also saw a substantial fall in profitability, with a 325.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.83%.

Apicore Pharmaceuticals revenue growth over time
Apicore Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.41%
*******
*******
*******
*******
Revenue from Operations
*******
 17.38%
*******
*******
*******
*******
Total Assets
*******
 90.98%
*******
*******
*******
*******
Profit or Loss
*******
 -325.99%
*******
*******
*******
*******
Net Worth
*******
 -40.83%
*******
*******
*******
*******
EBITDA
*******
 -48.11%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apicore Pharmaceuticals?

In 2023, Apicore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,675,940,785.00

Satisfied Charges

₹315,818,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 304.73 Cr
  • Axis Bank Limited : 101.78 Cr
  • Citi Bank N.A. : 57.00 Cr
  • Others : 4.09 Cr
Latest Charge Details
Date Lender Amount Status
03 Oct 2024 Hdfc Bank Limited ₹2.98 M Open
28 Feb 2024 Citi Bank N.A. ₹40.00 Cr Open
28 Feb 2024 Citi Bank N.A. ₹17.00 Cr Open
28 Feb 2023 Others ₹8.87 M Open
12 Jul 2022 Others ₹1.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Apicore Pharmaceuticals?

Apicore Pharmaceuticals has a workforce of 471 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apicore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apicore Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apicore Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited of Rs. 104.24 Cr registered on 26 Oct 2021 with Charge ID 100511376 was modified on 28 Oct 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 38.59 Cr registered on 31 Mar 2018 with Charge ID 100170349 was modified on 28 Oct 2025. was documented.

  • Charges

    A charge with Citi Bank N.A. of Rs. 40.00 Cr registered on 28 Feb 2024 with Charge ID 100887752 was modified on 09 Oct 2025. was recorded as a recent event.

  • Charges

    A charge registered on 21 Nov 2017 via Charge ID 100138414 with Axis Bank Limited was fully satisfied on 02 Nov 2024. was recorded as a recent event.

  • Annual General Meeting

    The activity Apicore Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Oct 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100982598 was registered on 03 Oct 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Apicore Pharmaceuticals Private Limited?

The CIN of Apicore Pharmaceuticals Private Limited is U24119GJ2006FTC048777.

Where is Apicore Pharmaceuticals Private Limited headquartered?

Apicore Pharmaceuticals Private Limited is headquartered at Block No. 252-253, Village - Dhobikuva,, Padra, Gujarat, 391440.

When was Apicore Pharmaceuticals Private Limited incorporated?

Apicore Pharmaceuticals Private Limited was incorporated on 27 July 2006.

Who are the current directors of Apicore Pharmaceuticals Private Limited?

The current directors of Apicore Pharmaceuticals Private Limited are

What is the primary industry of Apicore Pharmaceuticals Private Limited?

The primary industry of Apicore Pharmaceuticals Private Limited is Manufacturing.

Is Apicore Pharmaceuticals Private Limited a listed company?

Apicore Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Apicore Pharmaceuticals Private Limited?

The authorized capital of Apicore Pharmaceuticals Private Limited is ₹51.00 Cr, and the paid-up capital is ₹50.12 Cr.

What is the compliance status of Apicore Pharmaceuticals Private Limited?

The compliance status of Apicore Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available